MSB 11.8% $1.57 mesoblast limited

CEO Itescu needs to go, page-140

  1. 1,508 Posts.
    lightbulb Created with Sketch. 3319
    Hi @nippy

    " Surely the biostatisticians realise that an AA is conditional on the stats holding up over time and ... "

    Honestly, I suspect they aren't required to exercise their imaginations that far. Re the availability of Accelerated Approval, different contributors to the review committee would have had the responsibility of considering any submissions on the conditions of approval. We don't know that detail.

    But your point is a good one, of course. If the source of the problem was something as mundane as a failure of imagination on the part of, say, the review biostatisticians or any review committee member, IMO it paints the very politically active Dr Marks in a very poor light i.e. that, despite his conflicting duties & the outrageous precedent he was creating, he could find reason to jump in & personally overrule his review committee on Sarepta's product, but not MSB's.

    Cheers
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.57
Change
-0.210(11.8%)
Mkt cap ! $1.792B
Open High Low Value Volume
$1.72 $1.74 $1.52 $15.63M 9.716M

Buyers (Bids)

No. Vol. Price($)
1 5127 $1.57
 

Sellers (Offers)

Price($) Vol. No.
$1.57 39613 3
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.